Lilly Does Not Anticipate Additional Wholesaler Destocking Through 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Wholesaler destocking of the ADHD therapy Strattera and the antidepressant Prozac reduced Lilly's U.S. sales by $30 mil. during the quarter, the company says. Sequential increase in Zyprexa sales is indicative of stabilizing prescribing trends for the atypical antipsychotic, Lilly says.